Buyout groups Advent, Blackstone and KKR are among those to have been alerted to the opportunity for portfolio of low-growth medicines
Source: Companies
Author
Harry Joiner
“… a dominant recruiter in the client-side multichannel ecommerce space …” — SearchEngineWatch.com